CPM
STRO icon

Connective Portfolio Management’s Sutro Biopharma STRO Stock Holding History

Connective Portfolio Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,500
Closed -$527K – 60
2021
Q4 		$527K Buy
+3,500
New +$627K 0.93% 40

Other funds holding STRO

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Connective Portfolio Management's STRO Position: Q1 2022 in Review

Connective Portfolio Management sold out of Sutro Biopharma (STRO) in Q1 2022, closing a stake of 3,500 shares — an estimated $527K sold.

Connective Portfolio Management first reported a position in STRO in Q4 2021 and held it in 1 quarter. The position peaked at $527K in Q4 2021. 114 funds tracked by Wall St. Rank hold STRO as of Q1 2022.

  • Connective Portfolio Management reported no remaining Sutro Biopharma position as of Q1 2022 after selling out during the quarter.
  • Connective Portfolio Management sold 3,500 Sutro Biopharma shares in Q1 2022, an estimated $527K.
  • Connective Portfolio Management first reported a position in Sutro Biopharma in Q4 2021 and held it in 1 quarter.
  • Connective Portfolio Management's Sutro Biopharma position peaked at $527K in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2022.

Based on Connective Portfolio Management's 13F filing for Q1 2022, filed 12 Apr 2022.